Similar articles for PMID: 24360663

Year	Number of Results
1998	2
2000	2
2001	1
2002	2
2003	1
2004	2
2005	1
2006	4
2007	8
2008	2
2009	6
2010	7
2011	12
2012	17
2013	25
2014	22
2015	21
2016	23
2017	17
2018	18
2019	24
2020	22
2021	17
2022	21
2023	8
2024	0

1

The prognostic value of ribonucleotide reductase small subunit M2 in predicting recurrence for prostate cancers.

Huang Y, Liu X, Wang YH, Yeh SD, Chen CL, Nelson RA, Chu P, Wilson T, Yen Y. Huang Y, et al. Urol Oncol. 2014 Jan;32(1):51.e9-19. doi: 10.1016/j.urolonc.2013.08.002. Urol Oncol. 2014. PMID: 24360663

2

Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma.

Han P, Lin ZR, Xu LH, Zhong Q, Zhu XF, Liang FY, Cai Q, Huang XM, Zeng MS. Han P, et al. Mol Med Rep. 2015 Jul;12(1):401-9. doi: 10.3892/mmr.2015.3360. Epub 2015 Feb 16. Mol Med Rep. 2015. PMID: 25695839

3

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.

Mazzu YZ, Armenia J, Nandakumar S, Chakraborty G, Yoshikawa Y, Jehane LE, Lee GM, Atiq M, Khan N, Schultz N, Kantoff PW. Mazzu YZ, et al. Mol Oncol. 2020 Aug;14(8):1881-1897. doi: 10.1002/1878-0261.12706. Epub 2020 May 31. Mol Oncol. 2020. PMID: 32385899 Free PMC article.

4

Overexpression of catalytic subunit M2 in patients with ovarian cancer.

Wang LM, Lu FF, Zhang SY, Yao RY, Xing XM, Wei ZM. Wang LM, et al. Chin Med J (Engl). 2012 Jun;125(12):2151-6. Chin Med J (Engl). 2012. PMID: 22884145

5

Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer.

Huang JG, Pedersen J, Hong MK, Harewood LM, Peters J, Costello AJ, Hovens CM, Corcoran NM. Huang JG, et al. BJU Int. 2013 May;111(6):921-7. doi: 10.1111/j.1464-410X.2012.11665.x. Epub 2013 Jan 25. BJU Int. 2013. PMID: 23350712

6

Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.

Huang L, Li M, Wang D, He J, Wu W, Zeng Q, Li J, Xiao M, Hu J, He Y, Li Y, Mai L, Liu W. Huang L, et al. Hum Pathol. 2016 Jan;47(1):109-14. doi: 10.1016/j.humpath.2015.08.021. Epub 2015 Sep 28. Hum Pathol. 2016. PMID: 26546252

7

Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer.

Song C, Kang T, Yoo S, Jeong IG, Ro JY, Hong JH, Kim CS, Ahn H. Song C, et al. Urol Oncol. 2013 Feb;31(2):168-74. doi: 10.1016/j.urolonc.2010.11.005. Epub 2011 Jun 29. Urol Oncol. 2013. PMID: 21719325

8

E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2.

Fang Z, Gong C, Liu H, Zhang X, Mei L, Song M, Qiu L, Luo S, Zhu Z, Zhang R, Gu H, Chen X. Fang Z, et al. Biochem Biophys Res Commun. 2015 Aug 21;464(2):407-15. doi: 10.1016/j.bbrc.2015.06.103. Epub 2015 Jun 18. Biochem Biophys Res Commun. 2015. PMID: 26093293

9

Expression status of ribonucleotide reductase small subunits hRRM2/p53R2 as prognostic biomarkers in stage I and II non-small cell lung cancer.

Hsu NY, Wu JY, Liu X, Yen Y, Chen CY, Chou MC, Lin CH, Lee H, Cheng YW. Hsu NY, et al. Anticancer Res. 2011 Oct;31(10):3475-81. Anticancer Res. 2011. PMID: 21965764

10

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L. Ploussard G, et al. BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30. BJU Int. 2011. PMID: 20883488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

244 results

Results by year